Proprietary AI analyst is now available
- Public Comps
- Aker BioMarine
Aker BioMarine Valuation Multiples
Discover Aker BioMarine's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Leche Gloria, Ülker, Westrock Coffee, AGT Food and Ingredients and more.
Aker BioMarine Overview
About Aker BioMarine
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Ingredients, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
Founded
2006
HQ

Employees
255
Website
Sectors
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialAker BioMarine Financials
Aker BioMarine reported last 12-month revenue of $230M and EBITDA of $50M.
In the same LTM period, Aker BioMarine generated $108M in gross profit, $50M in EBITDA, and $5M in net income.
Revenue (LTM)
Aker BioMarine P&L
In the most recent fiscal year, Aker BioMarine reported revenue of $218M and EBITDA of $43M.
Aker BioMarine is unprofitable as of last fiscal year, with gross margin of 45%, EBITDA margin of 20%, and net margin of (1%).
Financial data powered by Morningstar, Inc.
Aker BioMarine Stock Performance
Aker BioMarine has current market cap of $888M, and enterprise value of $1B.
Market Cap Evolution
Aker BioMarine's stock price is $10.13.
Aker BioMarine share price decreased by 15.6% in the last 30 days, and increased by 61.7% in the last year.
Aker BioMarine has an EPS (earnings per share) of $-0.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $888M | 0.0% | -15.6% | -9.9% | 61.7% | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAker BioMarine Valuation Multiples
Aker BioMarine trades at 4.6x EV/Revenue multiple, and 21.1x EV/EBITDA.
EV / Revenue (LTM)
Aker BioMarine Financial Valuation Multiples
As of June 15, 2026, Aker BioMarine has market cap of $888M and EV of $1B.
Aker BioMarine has a P/E ratio of 167.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Aker BioMarine Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Aker BioMarine Margins & Growth Rates
Aker BioMarine grew revenue by 12% and EBITDA by 38% in the last fiscal year.
In the most recent fiscal year, Aker BioMarine reported gross margin of 45%, EBITDA margin of 20%, and net margin of (1%).
Aker BioMarine Margins
Aker BioMarine Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Aker BioMarine Operational KPIs
Aker BioMarine's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.3M for the same period.
Aker BioMarine's Rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aker BioMarine's Rule of X is 53% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Aker BioMarine Competitors
Aker BioMarine competitors include Leche Gloria, Ülker, Westrock Coffee, AGT Food and Ingredients, John B. Sanfilippo & Son, Once Upon a Farm, Carozzi, Coca-Cola Embonor, Standard Foods and Armada Gida.
Most Aker BioMarine public comparables operate across Food & Beverages.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| 0.7x | 0.6x | 4.2x | 3.9x | |||
| 1.5x | 1.4x | 25.1x | 21.6x | |||
| 0.4x | 0.5x | 6.6x | 6.6x | |||
| 0.9x | - | 9.1x | - | |||
| 3.1x | 2.7x | 358.8x | 261.5x | |||
| 0.9x | - | 8.7x | - | |||
| 0.7x | - | 7.3x | - | |||
This data is available for Pro users. Sign up to see all Aker BioMarine competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Aker BioMarine
Aker BioMarine has acquired 1 company to date.
Last acquisition by Aker BioMarine was on August 8th 2017. Aker BioMarine acquired Neptune (Krill Oil inventory and IP) for $35M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Aker BioMarine
| Description | Neptune is a marine ingredient supplier that holds intellectual property and inventory for krill oil under the NKO brand, sourced from Antarctic waters. It provides phospholipid-rich krill oil, marine lipids, and specialty seed oils to supplement manufacturers in North America and Europe. The Quebec-based company maintains a global supply network for omega-3 concentrates and astaxanthin extracts used in nutritional supplements. |
| HQ Country | |
| HQ City | Laval |
| Deal Date | 8 Aug 2017 |
| Valuation | $35M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Aker BioMarine acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Aker BioMarine
| When was Aker BioMarine founded? | Aker BioMarine was founded in 2006. |
| Where is Aker BioMarine headquartered? | Aker BioMarine is headquartered in Norway. |
| How many employees does Aker BioMarine have? | As of today, Aker BioMarine has over 255 employees. |
| Is Aker BioMarine publicly listed? | Yes, Aker BioMarine is a public company listed on Oslo Børs. |
| What is the stock symbol of Aker BioMarine? | Aker BioMarine trades under AKBM ticker. |
| When did Aker BioMarine go public? | Aker BioMarine went public in 2020. |
| Who are competitors of Aker BioMarine? | Aker BioMarine main competitors include Leche Gloria, Ülker, Westrock Coffee, AGT Food and Ingredients, John B. Sanfilippo & Son, Once Upon a Farm, Carozzi, Coca-Cola Embonor, Standard Foods, Armada Gida. |
| What is the current market cap of Aker BioMarine? | Aker BioMarine's current market cap is $888M. |
| What is the current revenue of Aker BioMarine? | Aker BioMarine's last 12 months revenue is $230M. |
| What is the current revenue growth of Aker BioMarine? | Aker BioMarine revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Aker BioMarine? | Current revenue multiple of Aker BioMarine is 4.6x. |
| What is the current EBITDA of Aker BioMarine? | Aker BioMarine's last 12 months EBITDA is $50M. |
| What is Aker BioMarine's EBITDA margin? | Aker BioMarine's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Aker BioMarine? | Current EBITDA multiple of Aker BioMarine is 21.1x. |
| What is the current FCF of Aker BioMarine? | Aker BioMarine's last 12 months FCF is $6M. |
| What is Aker BioMarine's FCF margin? | Aker BioMarine's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Aker BioMarine? | Current FCF multiple of Aker BioMarine is 168.6x. |
| How many companies Aker BioMarine has acquired to date? | As of June 2026, Aker BioMarine has acquired 1 company. |
| What was the largest acquisition by Aker BioMarine? | $35M acquisition of Neptune (Krill Oil inventory and IP) on 8th August 2017 was the largest M&A Aker BioMarine has done to date. |
| What companies Aker BioMarine acquired? | Aker BioMarine acquired Neptune (Krill Oil inventory and IP). |
| In how many companies Aker BioMarine has invested to date? | Aker BioMarine hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Aker BioMarine
Lists including Aker BioMarine
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
